title: [Clinical evaluation of serum NSE (neuron specific enolase) levels in cases of small cell lung cancer].
authors.forename: H
authors.initials: H
authors.lastname: Moriya
authors.forename: S
authors.initials: S
authors.lastname: Hisa
authors.forename: T
authors.initials: T
authors.lastname: Satoh
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: K
authors.initials: K
authors.lastname: Kimura
authors.forename: Y
authors.initials: Y
authors.lastname: Higuchi
authors.forename: K
authors.initials: K
authors.lastname: Hoshi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000175:diagnosis* / Q000188:drug therapy; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D013902:Radiography, Thoracic
chemical_list: D014408:Biomarkers, Tumor; D005047:Etoposide; D003520:Cyclophosphamide; D010751:Phosphopyruvate Hydratase; D002945:Cisplatin